If they paid out most of the cash currently held, (somewhere between $20m and $25m), there could be 20c+ per share available, assuming all applicable tax has been paid. This is hardly enough to make a significant difference to most people's voting decisions.
In practice, of course, the question is essentially academic, as it is unlikely that the Scheme of Arrangement will get up at anywhere near the current price offered by Qiagen.
The CST Board appear to have been blissfully unaware of shareholder feelings and expectations, and to be quite out if touch with reality. In conveying a false impression to Qiagen, CST Board have put themselves in the position of almost certainly plastering large amounts of egg on the faces of the senior members of both companies.
Shareholders have a right to expect a much more sensitive performance from the directors they elect.
- Forums
- ASX - By Stock
- CST
- franking credit component
franking credit component, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online